Abbott Says Chinese Market Not Affected By Recall Of Infant Formula

October 12, 2010 | Print | Email Email | Comments | Category: Consumer, Health




Abbott Laboratories, a pharmaceuticals health care company based in the U.S, has said that the Chinese market was not affected by its voluntary recall of its Similac-brand powder infant formula.

The company said that no products distributed in China by Abbott Nutrition were affected by the recent proactive and voluntary recall of some products in the USA, Puerto Rico, Guam, and some Caribbean countries.

The company further explained that the products distributed in China were produced in New Zealand, Europe, and Singapore, unlike those being recalled, which were produced in the USA.

On September 22, 2010, Abbott announced the recall of these products following an internal quality review that detected the remote possibility of the presence of a small common beetle in the product produced in one production area of a single manufacturing facility.

Rate this page: 1 Star2 Stars3 Stars4 Stars5 Stars

Loading...



Leave A Comment:



Inside ChinaCSR.com